Lemon Bottle 5x10ml
Important Notice
Regulated medical device (EU MDR 2017/745). For sale exclusively to qualified healthcare professionals.
What this purchase includes
- Original productFrom the manufacturer or an official distributor, CE marked.
- Batch and expiry documentedRecorded per unit on the delivery note and the invoice.
- Controlled storageOur own Madrid warehouse, 12 to 18 °C under 24 h control.
- Dispatch in 24 to 48 hFrom Madrid, insured and with a tracking number.
- Reachable Monday to Friday9:00 to 17:00 by WhatsApp and email. People, not forms.
Lemon Bottle is a solution from the Korean company Janytree Inc. (Seoul) formulated with riboflavin, lecithin and bromelain, and widely distributed in the aesthetic sector under the designation "lipolytic solution". The manufacturer declares it as a cosmetic product for external use. It has no authorisation as a medicinal product and no CE marking as a medical device for injectable use in the European Union, and it has been the subject of official warnings from European health authorities. Read the regulatory section in full before considering its use.
- Declared components riboflavin, lecithin, bromelain
- Contents 5 vials × 10 ml
- Manufacturer's declaration cosmetic for external use
- EU status no authorisation as a medicinal product or medical device
Regulatory status — essential information
This information is set out prominently because it determines any decision on use.
- Manufacturer's declaration: Lemon Bottle is labelled and marketed as a cosmetic product for external use. The manufacturer does not declare it as an injectable product.
- No medicinal product authorisation: the product has no marketing authorisation as a medicinal product in Spain or in the European Union.
- No CE marking as a medical device for an injectable lipolysis indication. No certification of this kind is documented for the product.
- Swissmedic warning (26 March 2024): the Swiss authority classified the lipolysis solution "Lemon Bottle" as a medicinal product because of its injectable route of administration and warned that it is not authorised for distribution in Switzerland. It further noted that its effect is not scientifically demonstrated and that the quality of the components is not verified.
- Swissmedic laboratory analysis: in seized samples, one contained only caffeine and another contained none of the components declared on the packaging; the content varied considerably between batches. There is therefore a documented risk of counterfeiting associated with this trade name.
- Distributor addendum (25 June 2024) reported by Swissmedic itself: the distributor SID Medicos stated that it could not verify the authenticity of the samples analysed and clarified that the original product is labelled exclusively for external cosmetic use.
- Warning from the General Pharmaceutical Council of the United Kingdom (10 April 2025): the British regulator described the product as "unlicensed and unregulated" and recalled that unlicensed medicinal products are not required to meet the safety and efficacy standards demanded of medicines.
Practical consequence: the injectable use of this product is not covered by any health authorisation in the European Union. Any application other than that declared by the manufacturer — external cosmetic use — takes place outside the regulatory framework and under the sole responsibility of the professional, with the implications this carries in terms of civil liability and insurance cover. In all cases, verify the traceability and authenticity of the supply.
Declared composition
- Riboflavin (vitamin B2).
- Lecithin.
- Bromelain, a proteolytic enzyme obtained from pineapple.
The manufacturer does not publish quantitative concentrations for any of the three components, nor a complete list of excipients. For this reason this data sheet reproduces no composition figures.
The product does not contain sodium deoxycholate, the active ingredient of the injectable lipolysis products authorised as medical devices in Europe. This difference in composition is relevant: the efficacy and safety data for those products are not transferable to Lemon Bottle.
Technical data
| Manufacturer | Janytree Inc. — Seoul, South Korea |
|---|---|
| Declared components | Riboflavin, lecithin, bromelain |
| Concentrations | Not published by the manufacturer |
| Presentation | 5 vials of 10 ml (50 ml in total) |
| Classification declared by the manufacturer | Cosmetic product for external use |
| Medicinal product authorisation (EU/Spain) | No |
| CE marking as a medical device | Not documented |
| Official warnings | Swissmedic (26.03.2024); General Pharmaceutical Council, United Kingdom (10.04.2025) |
Storage and pack contents
- Storage: store in the original packaging, protected from direct sunlight and heat sources, under the conditions stated on the packaging.
- Do not use after the expiry date stated on the packaging.
- Single-use vial.
- The pack includes: 5 vials of 10 ml.
Warnings
No manufacturer documentation is available establishing an application protocol, a dosage, a plane of administration or a list of contraindications for this product. This data sheet does not reproduce application protocols from unofficial sources.
There are no published, peer-reviewed clinical trials supporting the efficacy or safety of this formulation for the reduction of fat deposits.
Bromelain may cause hypersensitivity reactions in patients allergic to pineapple or latex. Lecithin of plant origin may be derived from soya, with the corresponding allergological relevance.
In case of any doubt about the regulatory status of the product in Spain, consult the Spanish Agency of Medicines and Medical Devices (AEMPS).
Product intended exclusively for professionals. This data sheet sets out the information published by the manufacturer and the warnings issued by European health authorities. It does not constitute a recommendation for injectable use, nor does it assert the existence of any health authorisation for that route. The decision and the responsibility regarding use of the product rest with the professional, in accordance with the applicable national regulations.